Menu
GeneBe

GNPDA1

glucosamine-6-phosphate deaminase 1

Basic information

Region (hg38): 5:141991748-142013041

Previous symbols: [ "GNPI" ]

Links

ENSG00000113552NCBI:10007OMIM:601798HGNC:4417Uniprot:P46926AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GNPDA1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNPDA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
13
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 0 0

Variants in GNPDA1

This is a list of pathogenic ClinVar variants found in the GNPDA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-142003157-G-A not specified Uncertain significance (Oct 22, 2021)2218701
5-142003210-A-G not specified Uncertain significance (Jun 21, 2022)2404101
5-142003244-C-G not specified Uncertain significance (Mar 04, 2024)3100679
5-142004946-T-C not specified Uncertain significance (Jan 03, 2024)3100678
5-142004963-A-G not specified Uncertain significance (Apr 07, 2022)2282124
5-142005065-A-T not specified Uncertain significance (Feb 06, 2024)3100677
5-142006224-T-G not specified Uncertain significance (Nov 29, 2023)3100676
5-142006233-A-G not specified Uncertain significance (Sep 17, 2021)2251688
5-142006242-G-A not specified Uncertain significance (Feb 27, 2023)2489089
5-142006264-T-C not specified Uncertain significance (Jun 29, 2023)2608661
5-142006287-A-G not specified Uncertain significance (Aug 01, 2023)2602265
5-142006308-G-A not specified Uncertain significance (Mar 07, 2024)3100675
5-142011959-T-C not specified Uncertain significance (Jun 22, 2023)2605679

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GNPDA1protein_codingprotein_codingENST00000508177 621293
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.60e-70.2371257180301257480.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.791041690.6140.000009161929
Missense in Polyphen3567.2780.52023776
Synonymous-0.5457569.21.080.00000446528
Loss of Function0.2841112.10.9125.74e-7149

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003600.000360
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001600.000158
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to trigger calcium oscillations in mammalian eggs. These oscillations serve as the essential trigger for egg activation and early development of the embryo (By similarity). {ECO:0000250}.;
Pathway
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II;Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Sialuria or French Type Sialuria;Sialuria or French Type Sialuria;Amino Sugar Metabolism;G(M2)-Gangliosidosis: Variant B, Tay-sachs disease;Tay-Sachs Disease;Salla Disease/Infantile Sialic Acid Storage Disease;<i>N</i>-acetylglucosamine degradation II;Aminosugars metabolism;Metabolism of carbohydrates;Fructose Mannose metabolism;<i>N</i>-acetylglucosamine degradation I;Metabolism;Glycolysis;Glucose metabolism (Consensus)

Recessive Scores

pRec
0.164

Intolerance Scores

loftool
0.637
rvis_EVS
-0.47
rvis_percentile_EVS
23.04

Haploinsufficiency Scores

pHI
0.255
hipred
Y
hipred_score
0.528
ghis
0.587

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.981

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gnpda1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
carbohydrate metabolic process;glucosamine catabolic process;N-acetylglucosamine catabolic process;UDP-N-acetylglucosamine biosynthetic process;generation of precursor metabolites and energy;single fertilization;N-acetylneuraminate catabolic process
Cellular component
cytoplasm;cytosol;extracellular exosome
Molecular function
glucosamine-6-phosphate deaminase activity;protein binding;identical protein binding